Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160708858> ?p ?o ?g. }
- W2160708858 endingPage "2164" @default.
- W2160708858 startingPage "2153" @default.
- W2160708858 abstract "ABSTRACT Broad and potent neutralizing antibody (BNAb) responses are rare in people infected by human immunodeficiency virus type 1 (HIV-1). Clearly defining the nature of BNAb epitopes on HIV-1 envelope glycoproteins (Envs) targeted in vivo is critical for future directions of anti-HIV-1 vaccine development. Conventional techniques are successful in defining neutralizing epitopes in a small number of individual subjects but fail in studying large groups of subjects. Two independent methods were employed to investigate the nature of NAb epitopes targeted in 9 subjects, identified by the NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI) 001 and 008 clinical teams, known to make a strong BNAb response. Neutralizing activity from 8/9 subjects was enhanced by enriching high-mannose N-linked glycan (HM-glycan) of HIV-1 glycoproteins on neutralization target viruses and was sensitive to specific glycan deletion mutations of HIV-1 glycoproteins, indicating that HM-glycan-dependent epitopes are targeted by BNAb responses in these subjects. This discovery adds to accumulating evidence supporting the hypothesis that glycans are important targets on HIV-1 glycoproteins for BNAb responses in vivo , providing an important lead for future directions in developing NAb-based anti-HIV-1 vaccines." @default.
- W2160708858 created "2016-06-24" @default.
- W2160708858 creator A5004036928 @default.
- W2160708858 creator A5014792433 @default.
- W2160708858 creator A5035889887 @default.
- W2160708858 creator A5042838345 @default.
- W2160708858 creator A5051827275 @default.
- W2160708858 creator A5071476197 @default.
- W2160708858 creator A5090699167 @default.
- W2160708858 date "2012-02-15" @default.
- W2160708858 modified "2023-09-26" @default.
- W2160708858 title "High-Mannose Glycan-Dependent Epitopes Are Frequently Targeted in Broad Neutralizing Antibody Responses during Human Immunodeficiency Virus Type 1 Infection" @default.
- W2160708858 cites W1486483688 @default.
- W2160708858 cites W1505517942 @default.
- W2160708858 cites W1529498974 @default.
- W2160708858 cites W1549547959 @default.
- W2160708858 cites W1553292190 @default.
- W2160708858 cites W1564319411 @default.
- W2160708858 cites W1601713328 @default.
- W2160708858 cites W1628484047 @default.
- W2160708858 cites W1794879226 @default.
- W2160708858 cites W1969693189 @default.
- W2160708858 cites W1973581581 @default.
- W2160708858 cites W1981726195 @default.
- W2160708858 cites W1982488181 @default.
- W2160708858 cites W1984658478 @default.
- W2160708858 cites W1988105476 @default.
- W2160708858 cites W1993052631 @default.
- W2160708858 cites W1995466180 @default.
- W2160708858 cites W2006483986 @default.
- W2160708858 cites W2012362118 @default.
- W2160708858 cites W2013330052 @default.
- W2160708858 cites W2018899526 @default.
- W2160708858 cites W2019010081 @default.
- W2160708858 cites W2019583094 @default.
- W2160708858 cites W2025005245 @default.
- W2160708858 cites W2026950785 @default.
- W2160708858 cites W2034988550 @default.
- W2160708858 cites W2045135963 @default.
- W2160708858 cites W2048317707 @default.
- W2160708858 cites W2052604124 @default.
- W2160708858 cites W2053127269 @default.
- W2160708858 cites W2066039163 @default.
- W2160708858 cites W2068718867 @default.
- W2160708858 cites W2070746076 @default.
- W2160708858 cites W2074969682 @default.
- W2160708858 cites W2083627780 @default.
- W2160708858 cites W2083726777 @default.
- W2160708858 cites W2085577978 @default.
- W2160708858 cites W2086641359 @default.
- W2160708858 cites W2087859193 @default.
- W2160708858 cites W2089766500 @default.
- W2160708858 cites W2090763940 @default.
- W2160708858 cites W2096409198 @default.
- W2160708858 cites W2098781795 @default.
- W2160708858 cites W2103712192 @default.
- W2160708858 cites W2105853426 @default.
- W2160708858 cites W2108304375 @default.
- W2160708858 cites W2110499527 @default.
- W2160708858 cites W2113236498 @default.
- W2160708858 cites W2118820599 @default.
- W2160708858 cites W2121096721 @default.
- W2160708858 cites W2130132011 @default.
- W2160708858 cites W2131492616 @default.
- W2160708858 cites W2133017175 @default.
- W2160708858 cites W2135151522 @default.
- W2160708858 cites W2137939749 @default.
- W2160708858 cites W2138922145 @default.
- W2160708858 cites W2142839717 @default.
- W2160708858 cites W2143585030 @default.
- W2160708858 cites W2152708819 @default.
- W2160708858 cites W2153576963 @default.
- W2160708858 cites W2157964093 @default.
- W2160708858 doi "https://doi.org/10.1128/jvi.06201-11" @default.
- W2160708858 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3302386" @default.
- W2160708858 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22156525" @default.
- W2160708858 hasPublicationYear "2012" @default.
- W2160708858 type Work @default.
- W2160708858 sameAs 2160708858 @default.
- W2160708858 citedByCount "54" @default.
- W2160708858 countsByYear W21607088582012 @default.
- W2160708858 countsByYear W21607088582013 @default.
- W2160708858 countsByYear W21607088582014 @default.
- W2160708858 countsByYear W21607088582015 @default.
- W2160708858 countsByYear W21607088582016 @default.
- W2160708858 countsByYear W21607088582018 @default.
- W2160708858 countsByYear W21607088582020 @default.
- W2160708858 countsByYear W21607088582021 @default.
- W2160708858 countsByYear W21607088582022 @default.
- W2160708858 crossrefType "journal-article" @default.
- W2160708858 hasAuthorship W2160708858A5004036928 @default.
- W2160708858 hasAuthorship W2160708858A5014792433 @default.
- W2160708858 hasAuthorship W2160708858A5035889887 @default.
- W2160708858 hasAuthorship W2160708858A5042838345 @default.
- W2160708858 hasAuthorship W2160708858A5051827275 @default.
- W2160708858 hasAuthorship W2160708858A5071476197 @default.
- W2160708858 hasAuthorship W2160708858A5090699167 @default.
- W2160708858 hasBestOaLocation W21607088581 @default.